Tembexa Tablet, Film Coated
Product Images NDC 64678-010

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tembexa (NDC 64678-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emergent Biodefense Operations Lansing Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

FDA Label Image

Blister Carton Label (Image 02)

TEMBEXA is a 100mg tablet of brincidofovir. The package contains 4 tablets, with full prescribing information available inside. The tablets should not be divided, broken, or crushed, and direct contact with broken or crushed tablets should be avoided. The recommended dosage is 200mg (2 100mg tablets) taken orally once weekly for two doses on days 1 and 8. TEMBEXA can be taken with or without food. The package is child-resistant and should be kept out of reach of children. Store at 20°C to 25°C (66°F to 77°F). Dosage and administration instructions are included, and caution should be taken to avoid direct contact with the medication.*

FDA Label Image

Blister Pack Label (Image 03)

This is a medication called Tembexa, with a strength of 100mg per tablet. The medication is associated with Emergent BioSolutions Operations Lansing LLC.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.